IL259977B
Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
56 members in 27 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 201261686429 | United States of America | P | |
| 201261714719 | United States of America | P | |
| 2013032684 | United States of America | W |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| CA2869460A1 | Canada | A1 | |
| CA2986512A1 | Canada | A1 | |
| CA3152081A1 | Canada | A1 | |
| WO2013151774A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2013302400A1 | United States of America | A1 | |
| AU2013243873A1 | Australia | A1 | |
| SG11201406340QA | Singapore | A | |
| IL234703A0 | Israel | A0 | |
| KR20150002752A | Republic of Korea | A | |
| EP2833905A1 | European Patent Office (EPO) | A1 | |
| CN104411324A | China | A | |
| MX2014011965A | Mexico | A | |
| JP2015514109A | Japan | A | |
| EA201401096A1 | Eurasian Patent Organization (EAPO) | A1 | |
| HK1203844A | Hong Kong, China | A | |
| HK1203844A1 | Hong Kong, China | A1 | |
| KR20160033249A | Republic of Korea | A | |
| KR101626703B1 | Republic of Korea | B1 | |
| AU2013243873B2 | Australia | B2 | |
| NZ700073A | New Zealand | A | |
| JP2016188250A | Japan | A | |
| JP6042527B2 | Japan | B2 | |
| BR112014024848A2 | Brazil | A2 | |
| US2017290796A1 | United States of America | A1 | |
| KR101809858B1 | Republic of Korea | B1 | |
| US9913822B2 | United States of America | B2 | |
| EP2833905B1 | European Patent Office (EPO) | B1 | |
| CA2869460C | Canada | C | |
| ES2673093T3 | Spain | T3 | |
| LT2833905T | Lithuania | T | |
| TR2018009231T4 | Türkiye | T4 | |
| TR201809231T4 | Türkiye | T4 | |
| DK2833905T3 | Denmark | T3 | |
| PT2833905T | Portugal | T | |
| SI2833905T1 | Slovenia | T1 | |
| JP2018138613A | Japan | A | |
| HRP20181187T1 | Croatia | T1 | |
| RS57449B1 | Serbia | B1 | |
| MX360092B | Mexico | B | |
| CN108686203A | China | A | |
| JP6422920B2 | Japan | B2 | |
| US10137104B2 | United States of America | B2 | |
| HUE038744T2 | Hungary | T2 | |
| IL259977A | Israel | A | |
| PL2833905T3 | Poland | T3 | |
| US2019083449A1 | United States of America | A1 | |
| EA031986B1 | Eurasian Patent Organization (EAPO) | B1 | |
| EA201800552A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CY1120523T1 | Cyprus | T1 | |
| IL259977BThis record | Israel | B | |
| JP2019199479A | Japan | A | |
| IL234703A | Israel | A | |
| IL234703B | Israel | B | |
| ZA201406969B | South Africa | B | |
| CA2986512C | Canada | C | |
| MX2022013713A | Mexico | A |
Numbers
- Publication
- 259977
- Application
- 259977
Titles2
- English
- Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
- Hebrew
- טיפול משולב עם גורם אנטי–היאלורונאן וטקסאן מכוון גידול
Classification
- CPC, 25
- A61K31/337
- A61K38/47
- A61K47/643
- A61K47/56
- A61K47/60
- A61K9/0019
- A61K31/37
- A61K31/42
- A61K31/573
- A61K31/706
- A61K31/7068
- A61K31/7076
- A61K31/7088
- A61K45/06
- C12N9/003
- C12N9/2474
- C12Y105/01003
- C12Y302/01035
- A61P1/18
- A61P35/00
- A61P43/00
- A61K47/50
- A61K9/107
- A61K39/395
- A61K31/56